Amicus Therapeutics US LLC

General

Total Cases8

Active Cases3

Patents15

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

amicus-therapeutics

amicus-therapeutics

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
01/21/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	SO ORDERED, D.I. [195] Stipulation and Order to Amend Scheduling Order filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. (Fact Discovery completed by 2/21/2025, Opening Expert Reports due by 3/27/2025, Rebuttal Expert Reports due by 4/24/2025, Expert Discovery due by 6/5/2025, Proposed Pretrial Order due by 8/15/2025, A Pretrial Conference is set for 9/19/2025 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke, A 5-day Bench Trial is set for 9/29/2025 at 09:00 AM in Courtroom 2A before Judge Christopher J. Burke. See Stipulation for further details and deadlines.) Signed by Judge Christopher J. Burke on 01/21/2025. (smg) (Entered: 01/21/2025) SO ORDERED, D.I. [195] Stipulation and Order to Amend Scheduling Order filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. (Fact Discovery completed by 2/21/2025, Opening Expert Reports due by 3/27/2025, Rebuttal Expert Reports due by 4/24/2025, Expert Discovery due by 6/5/2025, Proposed Pretrial Order due by 8/15/2025, A Pretrial Conference is set for 9/19/2025 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke, A 5-day Bench Trial is set for 9/29/2025 at 09:00 AM in Courtroom 2A before Judge Christopher J. Burke. See Stipulation for further details and deadlines.) Signed by Judge Christopher J. Burke on 01/21/2025. (smg) (Entered: 01/21/2025)
01/21/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	SO ORDERED, D.I. [195] Stipulation and Order to Amend Scheduling Order filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. (Fact Discovery completed by 2/21/2025, Opening Expert Reports due by 3/27/2025, Rebuttal Expert Reports due by 4/24/2025, Expert Discovery due by 6/5/2025, Proposed Pretrial Order due by 8/15/2025, A Pretrial Conference is set for 9/19/2025 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke, A 5-day Bench Trial is set for 9/29/2025 at 09:00 AM in Courtroom 2A before Judge Christopher J. Burke. See Stipulation for further details and deadlines.) Signed by Judge Christopher J. Burke on 01/21/2025. (smg) (Entered: 01/21/2025) SO ORDERED, D.I. [195] Stipulation and Order to Amend Scheduling Order filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. (Fact Discovery completed by 2/21/2025, Opening Expert Reports due by 3/27/2025, Rebuttal Expert Reports due by 4/24/2025, Expert Discovery due by 6/5/2025, Proposed Pretrial Order due by 8/15/2025, A Pretrial Conference is set for 9/19/2025 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke, A 5-day Bench Trial is set for 9/29/2025 at 09:00 AM in Courtroom 2A before Judge Christopher J. Burke. See Stipulation for further details and deadlines.) Signed by Judge Christopher J. Burke on 01/21/2025. (smg) (Entered: 01/21/2025)
01/21/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	STIPULATION and [Proposed] Order to Amend Scheduling Order re 194 Oral Order,,, by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/21/2025)
01/21/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	STIPULATION and [Proposed] Order to Amend Scheduling Order re 194 Oral Order,,, by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/21/2025)
01/15/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	ORAL ORDER: The Court, having reviewed the parties’ Stipulation to Amend the Scheduling Order, (D.I. [189] ), hereby ORDERS that the parties shall submit a proposed Scheduling Order by no later than January 21, 2025 that includes a 5-day bench trial to begin on September 29, 2025 at 9:00 a.m. and a pretrial conference set for September 19, 2025 at 11:00 a.m., all in Courtroom 2A before Judge Christopher J. Burke. The Court notes that, at this time, it is not inclined to permit the filing of summary judgment motions on Section 101, and so the proposed Scheduling Order shall not include dates relating thereto. That said, to the extent that the parties believe it would serve efficiency for such a summary judgment motion to be filed in the case, by January 27, 2025, they may file a letter with the Court not to exceed two (2) single-spaced pages explaining why that is so. Ordered by Judge Christopher J. Burke on 01/15/2025. (smg) (Entered: 01/15/2025) ORAL ORDER: The Court, having reviewed the parties’ Stipulation to Amend the Scheduling Order, (D.I. [189] ), hereby ORDERS that the parties shall submit a proposed Scheduling Order by no later than January 21, 2025 that includes a 5-day bench trial to begin on September 29, 2025 at 9:00 a.m. and a pretrial conference set for September 19, 2025 at 11:00 a.m., all in Courtroom 2A before Judge Christopher J. Burke. The Court notes that, at this time, it is not inclined to permit the filing of summary judgment motions on Section 101, and so the proposed Scheduling Order shall not include dates relating thereto. That said, to the extent that the parties believe it would serve efficiency for such a summary judgment motion to be filed in the case, by January 27, 2025, they may file a letter with the Court not to exceed two (2) single-spaced pages explaining why that is so. Ordered by Judge Christopher J. Burke on 01/15/2025. (smg) (Entered: 01/15/2025)
01/15/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	ORAL ORDER: The Court, having reviewed the parties’ Stipulation to Amend the Scheduling Order, (D.I. [189] ), hereby ORDERS that the parties shall submit a proposed Scheduling Order by no later than January 21, 2025 that includes a 5-day bench trial to begin on September 29, 2025 at 9:00 a.m. and a pretrial conference set for September 19, 2025 at 11:00 a.m., all in Courtroom 2A before Judge Christopher J. Burke. The Court notes that, at this time, it is not inclined to permit the filing of summary judgment motions on Section 101, and so the proposed Scheduling Order shall not include dates relating thereto. That said, to the extent that the parties believe it would serve efficiency for such a summary judgment motion to be filed in the case, by January 27, 2025, they may file a letter with the Court not to exceed two (2) single-spaced pages explaining why that is so. Ordered by Judge Christopher J. Burke on 01/15/2025. (smg) (Entered: 01/15/2025) ORAL ORDER: The Court, having reviewed the parties’ Stipulation to Amend the Scheduling Order, (D.I. [189] ), hereby ORDERS that the parties shall submit a proposed Scheduling Order by no later than January 21, 2025 that includes a 5-day bench trial to begin on September 29, 2025 at 9:00 a.m. and a pretrial conference set for September 19, 2025 at 11:00 a.m., all in Courtroom 2A before Judge Christopher J. Burke. The Court notes that, at this time, it is not inclined to permit the filing of summary judgment motions on Section 101, and so the proposed Scheduling Order shall not include dates relating thereto. That said, to the extent that the parties believe it would serve efficiency for such a summary judgment motion to be filed in the case, by January 27, 2025, they may file a letter with the Court not to exceed two (2) single-spaced pages explaining why that is so. Ordered by Judge Christopher J. Burke on 01/15/2025. (smg) (Entered: 01/15/2025)
01/10/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	SO ORDERED, D.I. [190] Stipulation and Covenant Not to Sue Regarding U.S. Patent No. 12,109,205 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 01/08/2025. (smg) (Entered: 01/10/2025)
01/10/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	SO ORDERED, D.I. [191] Stipulation and Order to Narrow the Remaining Issues Between Plaintiffs and Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 01/08/2025. (smg) (Entered: 01/10/2025)
01/10/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	SO ORDERED, D.I. [190] Stipulation and Covenant Not to Sue Regarding U.S. Patent No. 12,109,205 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 01/08/2025. (smg) (Entered: 01/10/2025)
01/10/25	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	SO ORDERED, D.I. [191] Stipulation and Order to Narrow the Remaining Issues Between Plaintiffs and Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 01/08/2025. (smg) (Entered: 01/10/2025)